摘要
目的探讨临床上使用尼莫地平注射液治疗脑卒中相关性头痛的疗效。方法选择我院2011-03—2012-05收治的186例脑卒中相关性头痛患者为研究对象,随机分为2组即治疗组和对照组,每组93例,对照组患者采用麦角胺类制剂和氟桂利嗪胶囊治疗,治疗组采用尼莫地平注射液治疗,1次/d,疗程为1周。结果治疗组效果明显优于对照组(P<0.05);治疗组不良反应发生率明显低于对照组,差异有统计学意义(P<0.05)。结论临床上使用尼莫地平注射液治疗脑卒中相关性头痛疗效确切,不良反应发生率低。
Objective To explore the curative effect of nimodipine injection on treating stroke-associated headache.Methods 186 patients with stroke-associated headache in our hospital from March 2011 to May 2012 were randomly divided into the control group(93 caese,treated by ergotamine agents and flunarizine hydrochloride capsules) and the treatment group(93 caese,treated by nimodipine injection,once a day,for one week).Results The curative effect of the treatment group was better than that in the control group(P0.05);The adverse reactions in the treatment group was lower than that in the control group(P0.05),which had a significant difference.Conclusion The nimodipine injection on treating stroke-associated headache has a certain curative effect and lower adverse reaction.
出处
《中国实用神经疾病杂志》
2013年第16期30-31,共2页
Chinese Journal of Practical Nervous Diseases